Comparison of ACTA and KORUS FTA Internet Provisions
Though negotiations are still underway on the South Korean – US Free Trade Agreement (KORUS FTA), the officially released version features significantly more strenuous provisions regarding IP...
View ArticleThe TPP Free Trade Agreement May Affect the Medicare Part B Program
The U.S. has recently begun to include in free trade agreements provisions regarding government health care programs which reimburse entities for prescription drugs. The U.S.-Australia free trade...
View ArticleNew Trend in Free Trade Agreements Could Affect U.S. Health Care Programs
As the latest round of negotiations for the Trans Pacific Partnership (TPP) free trade agreement starts this week in Vietnam, some member countries are publicly defending their prescription drug...
View ArticleDo Free Trade Agreement Pharmaceutical Chapters Promote “Off-Label” Marketing?
Recent free trade agreements with Korea and Australia have included provisions regulating pharmaceutical reimbursement programs operated at the “central level of government” of member countries....
View ArticleThe 340B Program is Not Exempt from the US-Korea Free Trade Agreement
The U.S. has recently begun to include in free trade agreements provisions regarding government health care programs which reimburse entities for prescription drugs. The U.S.-Australia free trade...
View ArticleAre U.S. Health Care Program Drug Prices Based on “Competitive Market-Derived...
Recent U.S. free trade agreements have included language regulating the way in which member countries manage their pharmaceutical drug coverage and reimbursement programs. The U.S.-Australia agreement...
View ArticleIn Mock Markup, Sen. Hatch Offers IP-Related Riders to the Korea-FTA...
Members of the Senate Finance Committee offered 97 amendments to legislation meant to implement the three bilateral free trade agreements pending in Congress at a “mark mock up” (which was boycotted by...
View ArticleConsistency of Korea-US Free Trade Agreement Copyright Provisions with U.S. Law
Heesob Nam recently requested me to give an opinion on whether the intellectual property provisions of the Korea-US Free Trade Agreement [KORUS] are fully consistent with U.S. law. The U.S. Congress...
View ArticleTPP Negotiators Turn to Pharmaceutical Reimbursement
MELBOURNE, AUSTRALIA. Negotiations of the Transpacific Partnership Agreement (TPP) have turned to discussions of the pharmaceutical reimbursement chapter today. This issue is highly controversial and...
View ArticleTrade Associations Write USTR on TPP, Seek Levels of IPR Protection Found in...
A coalition of 22 trade groups have written a letter on the Trans Pacific Partnership to U.S. Trade Representative Ron Kirk that focuses mainly on services and investment. However, the letter also...
View ArticleUSTR Announces New Pharmaceutical Intellectual Property Proposals for Trans...
[Updated Dec 3, 2013]. USTR released a document describing several policy changes in its Trans Pacific Partnership trade agreement proposals on provisions related to the prices of medicines. It is not...
View ArticleTPP and Withdrawn Proposals of the US in the negotiation of the US-Korea FTA
[Cross posted on Heesob's IP Blog] The followings were demanded by the U.S. negotiators but eventually withdrawn during the negotiation of FTA with South Korea. Patent term extension due to an approval...
View ArticleSen. Hatch – Obama Administration Should More Aggressively Use Trade Policy...
This morning, Sen. Orrin Hatch spoke about international intellectual property issues at the U.S. Chamber of Commerce. He was the keynote at the organization’s launch of the second edition of its...
View ArticleResponding to Frequently Asked Questions: TPP TTIP Pharmaceutical...
Brand name pharmaceutical companies are advocating for inclusion of disciplines on public pharmaceutical reimbursement programs in the ongoing negotiations of the Trans-Pacific Partnership agreement...
View ArticleUS Ambassador Confirmed Patent Linkage Under Korea-US FTA Includes Biologics...
[Cross posted from Heesob’s IP Blog, Link] One of the controversies in implementing the KorUS FTA is whether biological products are subject to the patent linkage obligation of the KorUS FTA. The...
View Article
